Hakon Leffler
Directeur/Membre du Conseil chez Lundonia Biotech AB
Profil
Hakon Leffler is the founder of Galecto Biotech ApS and Galecto, Inc. which were both founded in 2011.
He is currently a Director at Lundonia Biotech AB and a Professor at the University of Lund.
He was previously a Principal at the University of California, San Francisco.
Postes actifs de Hakon Leffler
| Sociétés | Poste | Début |
|---|---|---|
Lundonia Biotech AB
 Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Lundonia Biotech AB provides academic and industrial research and development services with diagnostic tools. Its products include GlycoWell microplates, affinity matrices, fluorophorc labelled saccharides and neo-glycoproteins for use as inhibitors, and reagents for covalent linkage to proteins and surfaces. The company was founded by Ulf Jörgen Nilsson and is headquartered in Lund, Sweden. | Directeur/Membre du Conseil | 06/07/2009 |
| University of Lund | Corporate Officer/Principal | - |
Anciens postes connus de Hakon Leffler
| Sociétés | Poste | Fin |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
| GALECTO, INC. | Fondateur | - |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GALECTO, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Lundonia Biotech AB
Lundonia Biotech AB Miscellaneous Commercial ServicesCommercial Services Lundonia Biotech AB provides academic and industrial research and development services with diagnostic tools. Its products include GlycoWell microplates, affinity matrices, fluorophorc labelled saccharides and neo-glycoproteins for use as inhibitors, and reagents for covalent linkage to proteins and surfaces. The company was founded by Ulf Jörgen Nilsson and is headquartered in Lund, Sweden. | Commercial Services |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |